AVXL (Anavex Life Sciences) Tariff Resilience Score: 4/10 (As of Jul. 02, 2026)


AVXL Anavex Life Sciences Corp AVXL
30 GF Score
Price $2.76
! 1 Warning Sign
View Full Analysis

What is Anavex Life Sciences Tariff Resilience Score?

Anavex Life Sciences AVXL +7.39% 30 Tariff Resilience Score is 4 as of Jul. 02, 2026. GuruFocus rates AVXL with a GF Score™ of 30/100. The stock has 1 warning sign investors should review. Among 1,374 Biotechnology companies, Anavex Life Sciences ranks better than 52.33% on this metric.

Anavex Life Sciences has the Tariff Resilience Score of 4, which implies that the company might have Average Resilient.

Anavex Life Sciences has Anavex's reliance on international clinical trials and raw material imports makes it vulnerable to tariffs. The company has limited historical exposure but lacks significant mitigation strategies. Its focus on R&D over manufacturing limits its ability to shift production locations.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Anavex Life Sciences might have Average Resilient.

Anavex Life Sciences  (NAS:AVXL) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Anavex Life Sciences Tariff Resilience Score Related Terms

AVXL vs SLGL, FATE, FHTX: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Anavex Life Sciences's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anavex Life Sciences Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anavex Life Sciences's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Anavex Life Sciences's Tariff Resilience Score falls into.


AVXL
30GF Score
Anavex Life Sciences Corp AVXL
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 4 mean?
Anavex Life Sciences (AVXL) has a Tariff Resilience Score of 4 as of Jul. 02, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Anavex Life Sciences ranks #655 out of 1374 companies in the Biotechnology industry, placing it in the top 47.7%.
Is Anavex Life Sciences' Tariff Resilience Score too high?
Anavex Life Sciences' current Tariff Resilience Score is 4. The Biotechnology industry median Tariff Resilience Score is 4.00. Anavex Life Sciences' value of 4 is 0% at this industry median. Based on the distribution chart, Anavex Life Sciences ranks #655 out of 1374 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Anavex Life Sciences has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Anavex Life Sciences' Tariff Resilience Score compare to SLGL and FATE?
According to the Biotechnology industry distribution chart, Anavex Life Sciences ranks #655 out of 1374 companies for Tariff Resilience Score. This puts Anavex Life Sciences in the upper half of its industry. The industry median Tariff Resilience Score is 4.00. Anavex Life Sciences' value of 4 is 0% at this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,374 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Anavex Life Sciences's current Tariff Resilience Score of 4 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Anavex Life Sciences's current Tariff Resilience Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anavex Life Sciences stock overvalued right now?
Anavex Life Sciences (AVXL) has a current Tariff Resilience Score of 4. The current Tariff Resilience Score is 4 and 0% at the Biotechnology industry median of 4.00. Anavex Life Sciences' overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Anavex Life Sciences (AVXL), the current Tariff Resilience Score is 4 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anavex Life Sciences Business Description

Other Exchanges 0HFR:UK12X1:Germany
Address 630 5th Avenue, 20th Floor, New York, NY, USA, 10111
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.
30GF Score

Get the complete analysis for AVXL

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.76
Price